skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.10e (Release date: 2017-10-30)
SearchBox Top
SearchBox Bottom
Recombinant Fowlpox-Tyrosinase Vaccine (Code C2807)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Recombinant Fowlpox-Tyrosinase Vaccine

Definition: A recombinant fowlpox virus vaccine with potential antineoplastic activity. Binding to the melanoma antigen tyrosinase, recombinant fowlpox-tyrosinase vaccine generates cellular immune responses against melanoma cells expressing the tyrosinase antigen; this effect is enhanced by the co-administration of interleukin 2 (IL-2). Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.

Label: Recombinant Fowlpox-Tyrosinase Vaccine

NCI Thesaurus Code: C2807 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1327884  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Recombinant Fowlpox-Tyrosinase Vaccine
rF-TYR vaccine
Tyrosinase-Fowl Pox

External Source Codes: 
NSC Code 702141 (see NCI DTP info)
PDQ Closed Trial Search ID 271373
PDQ Open Trial Search ID 271373 (check for NCI PDQ open clinical trial info)
UMLS CUI C1327884

Other Properties:
     Name Value (qualifiers indented underneath)
code C2807
Legacy_Concept_Name Fowlpox-Tyrosinase_Vaccine
Semantic_Type Pharmacologic Substance
Semantic_Type Virus

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom